Home/Filings/4/0001104659-21-142471
4//SEC Filing

LUCI DAVID P 4

Accession 0001104659-21-142471

CIK 0001736243other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:05 PM ET

Size

6.0 KB

Accession

0001104659-21-142471

Insider Transaction Report

Form 4
Period: 2021-11-19
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2021-11-19$4.80/sh+5,200$24,9601,008,723 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    15,083
  • Common Stock

    (indirect: By Children)
    35,000

Issuer

Acurx Pharmaceuticals, Inc.

CIK 0001736243

Entity typeother

Related Parties

1
  • filerCIK 0001271123

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:05 PM ET
Size
6.0 KB